Skip to main content
NCBI home page
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2008 Feb-Mar;23(1):85–90. doi: 10.1177/1533317507311776

Serum Albumin Levels Predict Cognitive Impairment in Elderly Hip Fracture Patients

Eliyahu Hayim Mizrahi 1, Tzvia Blumstein 2, Marina Arad 3, Abraham Adunsky 4
PMCID: PMC10846191  PMID: 18174316

Abstract

The aim of this study was to investigate the possible interrelation of serum albumin levels and cognitive function of elderly hip fracture patients. The study involved 331 elderly patients with hip fractures, admitted for rehabilitation. Cognition was assessed by Mini-Mental State Examination (MMSE). MMSE scores less than 24 points were considered suggestive of cognitive impairment. Age, serum albumin levels, and previous stroke emerged as the only statistically significant parameters differing between those with MMSE score less than 24 or higher. After adjusting for confounding variables, the middle and lowest tertiles of serum albumin levels were associated with an increased risk of cognitive impairment (odds ratio 1.97, 95% confidence interval 1.15-3.38, P < .01 vs 3.06 and 1.79-5.23, P < .001, respectively). This study shows that lower serum albumin levels are independently associated with lower MMSE scores in hip fractured elderly patients, supporting the possible role of chronic low-grade inflammation in age-related cognitive decline.

Keywords: albumin, cognitive impairment, hip fracture, elderly

Full Text

The Full Text of this article is available as a PDF (96.9 KB).

Contributor Information

Eliyahu Hayim Mizrahi, Department of Geriatric Medicine & Rehabilitation, Sheba Medical Center, Tel Hashomer, the Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv Israel, exm42@sheba.health.gov.il .

Tzvia Blumstein, the Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer.

Marina Arad, Department of Geriatric Medicine & Rehabilitation, Sheba Medical Center, Tel Hashomer, the Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv Israel.

Abraham Adunsky, Department of Geriatric Medicine & Rehabilitation, Sheba Medical Center, Tel Hashomer, the Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv Israel.

References

  1. Dziedzic T. Systemic inflammatory markers and risk of dementia. Am J Alzheimers Dis Other Demen. 2006;21: 258-262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akiyama H., Barger S., Barmum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383-421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Eikelenboom P., Hack CE, Kamphorst W., et al. Distribution pattern and functional state of complement proteins and alpha1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease. Res Immunol. 1992;143:617-620. [DOI] [PubMed] [Google Scholar]
  4. McGeer EG , McGeer PL The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol. 1998;33:371-378. [DOI] [PubMed] [Google Scholar]
  5. Arends YM, Duyckaerts C., Rozemuller JM, Eikeleboom P., Hauw JJ Microglia, amyloid and dementia in Alzheimer disease. A correlative study. Neurobiol Aging. 2000;21:39-47. [DOI] [PubMed] [Google Scholar]
  6. Cagnin A., Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358:461-467. [DOI] [PubMed] [Google Scholar]
  7. Veerhuis R., Van Breemen MJ, Hoozemans JM, et al. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol. 2003;105:135-144. [DOI] [PubMed] [Google Scholar]
  8. Maes OC, Xu S., Yu B., Chertkow HW, Wang E., Schipper HM Transcriptional profiling of Alzheimer blood mononuclear cells by microarray . Neurobiol Aging. 2007;28:1795-1809. [DOI] [PubMed] [Google Scholar]
  9. Sala G., Galimberti G., Canevari C., et al. Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiol Aging. 2003. ;24:909-914. [DOI] [PubMed] [Google Scholar]
  10. Strandberg TE, Tilvis RS C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20:1057-1060. [DOI] [PubMed] [Google Scholar]
  11. Kálmán J., Juhász A., Laird G., et al. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand. 1997;96:236-240. [DOI] [PubMed] [Google Scholar]
  12. Dik MG, Jonker C., Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005;64: 1371-1377. [DOI] [PubMed] [Google Scholar]
  13. Yaffe K., Lindquist K., Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003;61:76-80. [DOI] [PubMed] [Google Scholar]
  14. Engelhart MJ , Geerlings MI, Meijer J., et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol. 2004;61:668-672. [DOI] [PubMed] [Google Scholar]
  15. Schmidt R., Schmidt H., Curb JD, Masaki K., White LR, Launer LJ Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol. 2002;52:168-174. [DOI] [PubMed] [Google Scholar]
  16. Ravaglia G., Forti P., Maioli F., et al. Serum c-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci. 2005;60:1017-1021. [DOI] [PubMed] [Google Scholar]
  17. Schram MT, Euser SM, de Craen JM, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc. 2007:55:708-716. [DOI] [PubMed] [Google Scholar]
  18. Zuccala G., Marzetti E., Cesari M., et al. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med. 2005;118:496-502. [DOI] [PubMed] [Google Scholar]
  19. Kimura R., Kamino K., Yamamoto M., et al. Albumin gene encoding free fatty acid and beta amyloid transporter is genetically associated with Alzheimer disease. Psychiatry Clin Neurosci. 2006;60(suppl 1):S34-S39. [Google Scholar]
  20. Adunsky A., Levi R., Cecic A., Arad M., Noy S., Barell V. The Sheba model of comprehensive orthogeriatric care for elderly hip fracture patients: a preliminary report. Isr Med Assoc J. 2002;4:259-261. [PubMed] [Google Scholar]
  21. Inouye SK, van Dyck CH, Alessi CA, Balkin S., Siegal AP, Horwitz RI Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941-948. [DOI] [PubMed] [Google Scholar]
  22. Folstein M. , Folstein S., McHugh PR Mini-Mental State Examination. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198. [DOI] [PubMed] [Google Scholar]
  23. Tombaugh TN , McIntyre NJ The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922-935. [DOI] [PubMed] [Google Scholar]
  24. Gruber-Baldini AL, Zimmerman S., Morrison RS, et al. Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc. 2003;51:1227-1236. [DOI] [PubMed] [Google Scholar]
  25. BelooseskyY. , Hendel D., Weiss A., et al. Cytokines and C-reactive protein production in hip-fracture operated elderly patients. J Gerontol A Biol Sci Med Sci. 2007;62:420-426. [DOI] [PubMed] [Google Scholar]
  26. Katz IR, Beaston-Wimmer P., Parmelee P., Friedman E., Lawton MP Failure to thrive in the elderly: exploration of the concept and delineation of psychiatric components. J Geriatr Psychiatry Neurol. 1993;6:161-169. [DOI] [PubMed] [Google Scholar]
  27. Mago R., Bilker W., Ten Have T., et al. Clinical laboratory measures in relation to depression, disability, and cognitive impairment in elderly patients. Am J Geriatr Psychiatry. 2000;8:327-332. [PubMed] [Google Scholar]

Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES